StonvexLoading…
StonvexStonvexStonvexCore line items from CLPT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $36.97M | $31.39M | $23.95M | $20.55M |
Operating Income | $-24.16M | $-19.73M | $-22.45M | $-16.33M |
Net Income | $-25.54M | $-18.91M | $-22.09M | $-16.43M |
EPS (Diluted) | $-0.90 | $-0.70 | $-0.90 | $-0.68 |
Total Assets | $97.75M | $39.19M | $42.66M | $55.49M |
Total Liabilities | $69.73M | $13.80M | $21.49M | $18.60M |
Cash & Equivalents | $45.92M | $20.10M | $23.14M | $27.61M |
Free Cash Flow OCF − CapEx | $-24.45M | $-9.22M | $-14.44M | $-16.42M |
Shares Outstanding | 29.37M | 27.62M | 24.65M | 24.58M |